Press Releases

11.03.2025

Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk

10.31.2025

Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement

10.31.2025

Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition

10.30.2025

Pfizer Addresses Proposal for Metsera

09.30.2025

Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients

09.22.2025

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio

07.24.2025

Pfizer Completes Licensing Agreement with 3SBio

05.19.2025

Pfizer Enters into Exclusive Licensing Agreement with 3SBio

04.24.2025

Pfizer Announces 2025 Shareholder Meeting Preliminary Results

04.10.2025

Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24

12.17.2024

Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance

12.10.2024

Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium